1. HBW Insight
  2. >>Health
  3. >>Innovation & IP
  4. >>Trademarks

Health And Wellness Trademark Review 27 April, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks Class 3 include cosmetics and cleaning preps and class 5 includes pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5. The list of Class 3 and Class 5 entries from the 27 April issue of the Official Gazette is linked below in a downloadable and searchable PDF.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Trademarks

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 9 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 2 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 26 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

More from Innovation & IP

Haleon Launches ‘Prescription Strength’ Hayfever Remedy In The UK

 
• By David Ridley

Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”

Haleon’s US Eroxon Launch Falls Short Of Expectations

 
• By Tom Gallen

Consumer uptake of Eroxon - the first FDA-approved OTC ED treatment available in the US - has been slower than expected, according to Haleon, which says its working with retailers to build awareness.

Over The Counter: The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley

 
• By David Ridley

Advercheck managing director James Walmsley talks to HBW Insight about the challenges facing consumer health companies today as they move away from the prescription medicines sector and its pipeline of switchable ingredients towards self-care and prevention.